Magazine Article | October 3, 2022

What Is A Risk-Based Approach To CRO Oversight?

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader

Ian Wyglendowski has experienced the pharma industry with companies of every size. He started his career at a small biotech (35 employees) and then went to work for Genetics Institute/ Wyeth and BMS. Throughout his career, he also worked with numerous CROs and today is the head of strategic clinical partnering at UCB. For him, CRO oversight always has been top of mind.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: